论文部分内容阅读
5月8日,国家发改委正式发布《发改委定价范围内的低价药品目录》该目录包含化药品种283个、中成药品种250个,共533个品种1154个剂型根据低价药的筛选标准:中成药日服用费用不超过5元,化学药日服用费用不超过3元据悉,李嘉诚旗下知名中药企业白云山和黄中药的主打品种白云山复方丹参片、白云山板蓝根、白云山消炎利胆片等共51个品种入选了该目录据广药集团董事长兼白云山和黄中药总经理李楚源介绍,白云山复方丹参片、白云山板蓝根、白云山消炎利胆片
May 8, the National Development and Reform Commission officially released the “NDRC pricing within the scope of the list of low-cost drugs,” the directory contains 283 varieties of drugs, 250 varieties of proprietary Chinese medicines, a total of 533 varieties of 1154 formulations based on low-cost drug screening criteria: It is reported that the famous Chinese medicine company Li Ka-shing's flagship Baiyun Mountain Chinese Herbs and the main varieties of Baiyun Mountain Compound Danshen Tablets, Baiyunshan Radix, Baiyunshan anti-inflammatory gallbladder tablets A total of 51 species were selected The directory According to Guangzhou Pharmaceutical Group chairman and general manager of Baiyunshan Huang Chu Chu introduction, Baiyun Mountain Compound Danshen tablets, Baiyunshan Banlangen, Baiyun Mountain Xiaoyanlidan tablets